Header Logo

Connection

Richard Fessler to Tacrolimus

Back to Details
This is a "connection" page, showing publications Richard Fessler has written about Tacrolimus.
Richard Fessler
Connection Strength
0.219
Tacrolimus
  1. A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury. J Neurosurg Spine. 2022 12 01; 37(6):812-820.
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.